Cagrilintide is a long-acting amylin analogue developed for laboratory pharmacological research. It is synthesized by solid-phase peptide synthesis and strictly purified by HPLC, with complete quality control records for each batch. This peptide mimics the biological activity of native amylin, regulating energy intake and metabolic balance in preclinical research models. Unlike many short-acting peptide analogues, its structural modification extends the in-vitro stability, making it suitable for long-duration cell and animal study projects. Our Cagrilintide powder undergoes full QC testing including HPLC for purity and mass spectrometry for molecular weight verification. Each batch can be supplied with COA document upon request. The lyophilized form minimizes degradation during transportation and storage, greatly preserving peptide integrity. It is widely adopted in academic and biotech laboratories for metabolic mechanism exploration, receptor interaction research and preclinical pharmacology evaluation.